Home › Cancro alla prostata › Distretto di Columbia › Washington
Studi clinici su Cancro alla prostata a Washington, DC
38 studi su Cancro alla prostata cercano partecipanti presso sedi a Washington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
The Vanguard Study: Testing a New Way to Screen for Cancer
In reclutamentoVolontari sani benvenuti
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
In reclutamentoFase 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collection of Blood From Patients With Prostate Cancer
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
In reclutamentoFase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Precision-Based Genomics in Prostate Cancer
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collection of Blood From Patients With Cancer
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
In reclutamentoFase 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
In reclutamentoFase 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
In reclutamentoFase 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
In reclutamentoFase 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · a 11 mi di distanza
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Men at High Genetic Risk for Prostate Cancer
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
In reclutamentoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
In reclutamento
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
In reclutamentoFase 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
In reclutamentoFase 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · a 7 mi di distanza
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
In reclutamentoFase 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
In reclutamentoFase 1
- Maryland Oncology Hematology, Silver Spring · a 7 mi di distanza
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
In reclutamentoFase 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
In reclutamento
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
In reclutamentoFase 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
In reclutamentoFase 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
In reclutamentoVolontari sani benvenuti
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · a 7 mi di distanza
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Silver Spring · a 7 mi di distanza
- Massive Bio SYNERGY-AI site, Bethesda · a 7 mi di distanza
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
In reclutamentoFase 3
- George Washington University Medical Center, Washington D.C.
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Dallas, TX36 studi
Altri studi a Washington
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule55 studi
- Cancro al seno46 studi
- Cancro metastatico43 studi
- Cancro ai polmoni41 studi
- Obesità33 studi
- Cancro colorettale29 studi
- Malattie cardiovascolari28 studi
- Cancro della vescica26 studi
- Leucemia mieloide acuta24 studi
- Cancro ovarico23 studi
- Linfoma23 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.